Tapewire

Nasdaq · USD

MDGL

MADRIGAL PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3441
SEC CIK
0001157601
Parsed reports
271

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025036
Dec 2025034
Jan 2026066
Feb 202600
Mar 2026017
Apr 202600
May 2026013
Jun 202601
Jul 2026010
Aug 202601
Sep 2026024
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 299 $535.80 $160,205.43
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 24

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 456,854

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F22 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.62 to $536.32, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 89 $534.93 $47,608.98
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 23

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 457,153

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F21 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.60 to $534.99, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 271 $534.18 $144,761.45
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 22

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 457,242

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F20 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.60 to $534.57, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 40 $532.50 $21,300.00
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 21

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 457,513

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 30 $531.05 $15,931.50
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 20

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 457,553

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 256 $530.45 $135,795.84
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 19

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 457,583

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.97 to $530.63, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 554 $529.28 $293,221.84
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 18

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 457,839

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.72 to $529.69, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 465 $528.16 $245,592.63
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 17

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 458,393

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.71 to $528.52, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 1,135 $526.95 $598,090.86
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 16

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 458,858

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.63 to $527.58, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 913 $526.05 $480,281.37
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 15

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 459,993

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.59 to $526.55, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 1,489 $525.12 $781,903.08
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 14

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 460,906

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.59 to $525.56, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 1,335 $524.06 $699,622.77
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 13

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 462,395

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $523.59 to $524.58, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 732 $522.98 $382,822.60
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 12

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 463,730

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $522.51 to $523.47, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 588 $521.95 $306,908.66
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 11

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 464,462

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.50 to $522.49, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 440 $521.11 $229,288.93
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 10

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 465,050

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.46 to $521.45, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 539 $519.89 $280,219.58
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 9

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 465,490

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.45 to $520.38, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 970 $518.67 $503,105.83
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 8

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 466,029

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.39 to $519.29, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 2,044 $517.84 $1,058,468.03
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 7

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 466,999

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.36 to $518.35, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 521 $516.81 $269,257.23
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 6

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 469,043

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.32 to $517.26, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 1,578 $515.82 $813,968.38
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 5

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 469,564

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.32 to $516.29, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 937 $514.63 $482,207.47
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 4

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 471,142

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.32 to $515.25, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 960 $513.12 $492,594.82
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 3

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 472,079

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $513.00 to $513.58, inclusive.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
SaleCommon Stock 960 $512.02 $491,537.18
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 2

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 473,039

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.71 to $512.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:34 UTC
Taub RebeccaDirector
Exercise / conversionCommon Stock 18,410 $15.80 $290,878.00
Disclosure

SEC source: 0001628280-26-001961 · wk-form4_1768340044.xml · nonDerivative · entry 1

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 473,999

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 24,800 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · derivative · entry 12

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,800

Underlying: Common Stock · 24,800 shares

Expires 2027-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC SaleCommon Stock 160 $555.39 $88,862.40
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 10

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,164

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC SaleCommon Stock 1,029 $555.00 $571,091.19
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 9

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,324

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.39 to $555.31, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC SaleCommon Stock 5,001 $553.83 $2,769,728.33
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 8

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,353

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.28 to $554.27, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC SaleCommon Stock 5,533 $552.74 $3,058,332.00
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 7

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 193,354

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.28 to $553.27, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC SaleCommon Stock 7,193 $551.67 $3,968,128.50
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 6

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,887

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.28 to $552.26, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC SaleCommon Stock 4,316 $550.93 $2,377,825.96
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 5

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,080

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.28 to $551.26, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC SaleCommon Stock 409 $549.99 $224,944.72
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 4

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,396

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.27 to $550.23, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC SaleCommon Stock 535 $548.51 $293,451.08
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 3

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,805

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.17 to $549.08, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC SaleCommon Stock 624 $547.75 $341,793.63
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 2

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,340

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.17 to $548.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:40 UTC Exercise / conversionCommon Stock 24,800 $15.80 $391,840.00
Disclosure

SEC source: 0001628280-25-056794 · wk-form4_1765575628.xml · nonDerivative · entry 1

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 18,650 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · derivative · entry 13

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,650

Underlying: Common Stock · 18,650 shares

Expires 2027-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
GiftCommon Stock 5,455 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 11

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 455,589

F10 · kind: The Reporting Person made a charitable contribution of 5,455 shares of common stock of the Issuer to a donor advised fund.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
SaleCommon Stock 200 $555.39 $111,078.00
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 10

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 461,044

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
SaleCommon Stock 1,027 $554.84 $569,822.43
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 9

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 461,244

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.39 to $555.31, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
SaleCommon Stock 3,087 $553.88 $1,709,826.02
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 8

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 462,271

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.39 to $554.33, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
SaleCommon Stock 3,857 $552.81 $2,132,196.66
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 7

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 465,358

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.39 to $553.38, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
SaleCommon Stock 4,410 $551.85 $2,433,641.30
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 6

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 469,215

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.39 to $552.38, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
SaleCommon Stock 4,723 $550.99 $2,602,307.35
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 5

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 473,625

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.39 to $551.38, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
SaleCommon Stock 486 $550.07 $267,334.75
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 4

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 478,348

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.38 to $550.37, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
SaleCommon Stock 369 $548.56 $202,417.87
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 3

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 478,834

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.17 to $549.00, inclusive.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
SaleCommon Stock 491 $547.76 $268,948.54
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 2

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 479,203

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.16 to $548.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:35 UTC
Taub RebeccaDirector
Exercise / conversionCommon Stock 18,650 $15.80 $294,670.00
Disclosure

SEC source: 0001628280-25-056792 · wk-form4_1765575309.xml · nonDerivative · entry 1

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 479,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2025 Filed Dec 4, 2025 22:26 UTC
Sibold William JohnDirector · President and CEO
SaleCommon Stock 2,400 $575.34 $1,380,816.00
Disclosure

SEC source: 0001628280-25-055430 · wk-form4_1764887216.xml · nonDerivative · entry 2

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,074

F2 · kind: The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover certain tax withholding obligations in connection with the Reporting Person earning 50,000 shares of common stock as described in Footnote 1 above. This sale was automatic and not at the discretion of the Reporting Person.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 22:26 UTC
Sibold William JohnDirector · President and CEO
Exercise / conversionPerformance Restricted Stock Units · Derivative 50,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-055430 · wk-form4_1764887216.xml · derivative · entry 3

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of Performance Restricted Stock Units with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award. Following the achievement of the first hurdle in February 2025 and the second hurdle reported on this line, the Reporting Person is eligible to earn an additional 50,000 shares upon the achievement of the final performance hurdle. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the Performance Restricted Stock Units.

F3 · price: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of Performance Restricted Stock Units with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award. Following the achievement of the first hurdle in February 2025 and the second hurdle reported on this line, the Reporting Person is eligible to earn an additional 50,000 shares upon the achievement of the final performance hurdle. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the Performance Restricted Stock Units.

F3 · derivative.exercise_date: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of Performance Restricted Stock Units with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award. Following the achievement of the first hurdle in February 2025 and the second hurdle reported on this line, the Reporting Person is eligible to earn an additional 50,000 shares upon the achievement of the final performance hurdle. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the Performance Restricted Stock Units.

F3 · derivative.expiration_date: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of Performance Restricted Stock Units with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award. Following the achievement of the first hurdle in February 2025 and the second hurdle reported on this line, the Reporting Person is eligible to earn an additional 50,000 shares upon the achievement of the final performance hurdle. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the Performance Restricted Stock Units.

F3 · balance_after: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of Performance Restricted Stock Units with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award. Following the achievement of the first hurdle in February 2025 and the second hurdle reported on this line, the Reporting Person is eligible to earn an additional 50,000 shares upon the achievement of the final performance hurdle. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the Performance Restricted Stock Units.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 22:26 UTC
Sibold William JohnDirector · President and CEO
Exercise / conversionCommon Stock 50,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-055430 · wk-form4_1764887216.xml · nonDerivative · entry 1

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,474

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On December 3, 2025, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 3. Pursuant to the terms of the award, certain of these shares were sold to cover certain tax withholding obligations as described in Footnote 2 below. The Issuer is irrevocably obligated to issue the remaining shares to the Reporting Person on September 8, 2028, the fifth anniversary of the commencement of his employment with the Issuer.

F1 · price: On December 3, 2025, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 3. Pursuant to the terms of the award, certain of these shares were sold to cover certain tax withholding obligations as described in Footnote 2 below. The Issuer is irrevocably obligated to issue the remaining shares to the Reporting Person on September 8, 2028, the fifth anniversary of the commencement of his employment with the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.